The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit.

Front Genet · 2022 · PMC9871364 · PMID 36704336

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Stage I/II and TLS-positive exhibited a favorable trend towards advanced 5-year OS.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.